← Open Payments lookup

COLLEEN GAFFNEY: Open Payments

NPI 1295957579 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$212 in 8 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $212

Food & beverage: $212
CompanyPaymentsAmount
UCB, Inc.1$33
Neurocrine BioSciences, Inc.1$32
CSL Behring1$28
Takeda Pharmaceuticals U.S.A., Inc.1$27
Alexion Pharmaceuticals, Inc.1$26
Axsome Therapeutics, Inc.1$25
EMD Serono, Inc.1$24
Lundbeck LLC1$17

Products named: Rystiggo, INGREZZA, Hizentra, HYQVIA, ULTOMIRIS, Symbravo, VYEPTI.

Industry payments across MD — which companies pay providers there.